Breaking News

Dabur India Plant Under US FDA Scanner Over Contamination Concerns

The United States Food and Drug Administration (US FDA) has flagged serious concerns at Dabur India's manufacturing facility in Silvassa, Dadra and Nagar Haveli, following an inspection conducted in...

FDA Approves Wockhardt’s Novel Antibiotic ZAYNICH™️ for cUTI

Wockhardt Limited  announced that the U.S. Food and Drug Administration (FDA) has approved ZAYNICH™ (cefepimeand zidebactam), a novel intravenous antibiotic...

Relief for Patients: NPPA Fixes Ceiling Prices for 30 Essential Medicines

The National Pharmaceutical Pricing Authority (NPPA) has notified ceiling prices for 30 essential fixed-dose combination medicines under the...

FDA Draft Guidance Aims to Reduce Animal Testing for Cancer Drugs

The U.S. Food and Drug Administration (FDA) issued a new draft guidance aimed at reducing unnecessary animal testing...

Top 15 Pharmacy Colleges in West Bengal: Complete Guide for Pharmacy Aspirants (2026)

Choosing the right pharmacy college is one of the most important steps for students planning a career in...

India’s CDSCO Bans Injectable Products From Being Marketed as Cosmetics

The Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, has issued a...

Sun Pharma Reports Strong Q4 with 26% Growth in Net Profit

Sun Pharmaceutical Industries Limited reported a strong fourth quarter for FY26, with consolidated net profit rising 26.2% year-on-year to ₹2,714 crore. Revenue for the quarter...

West Bengal Healthcare Gets Major Boost as Centre Reviews Key Health Schemes

Union Health Minister Jagat Prakash Nadda held a virtual review meeting with West Bengal officials to assess the state’s healthcare systems and discuss ways to strengthen...

J P Nadda Speaks on TB Prevention at Geneva Global Health Summit

India reinforced its commitment to tuberculosis prevention and stronger lung health screening as Union Health Minister Jagat Prakash Nadda addressed a key side-event on “Ministerial Perspectives...

Dr. Reddy’s Launches Affordable Oral Diabetes Drug in India

Dr. Reddy’s Laboratories has announced the launch of Obeda®, its oral semaglutide tablet for the treatment of Type 2 diabetes in India. The once-daily tablet...

North Bengal Set to Transform into a Leading Pharma Destination

West Bengal is intensifying its focus on pharmaceutical manufacturing as part of a broader industrial development strategy aimed at attracting investment and boosting economic...